COVID-19 is reshaping the pharmaceutical supply chain
Monday, April 27, 2020 - 00:10
in Mathematics & Economics
The coronavirus pandemic may mark a rebalancing of where drugs are made as nations recognize a security imperative
The coronavirus pandemic may mark a rebalancing of where drugs are made as nations recognize a security imperative